1-4 of 4
David J. Gnarra
Close
Sort by
Journal Articles

Long-Term Use of Open-Label Romiplostim in Children with Chronic/Refractory Immune Thrombocytopenia (ITP)

James B Bussel, MD, George R. Buchanan, MD, David J. Gnarra, MD, Richard H. Ho, MD, MSCI, Kun Nie, Melissa Eisen, MD
Journal: Blood
Blood (2012) 120 (21): 621.
https://doi.org/10.1182/blood.V120.21.621.621
Published: 2012
Journal Articles

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

Clinical Trials & Observations
James B. Bussel, George R. Buchanan, Diane J. Nugent, David J. Gnarra, Lisa R. Bomgaars, Victor S. Blanchette, Yow-Ming Wang, Kun Nie, Susie Jun
Journal: Blood
Blood (2011) 118 (1): 28–36.
https://doi.org/10.1182/blood-2010-10-313908
Published: 2011
Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).

George R. Buchanan, MD, Lisa Bomgaars, MD, James B. Bussel, MD, Diane J. Nugent, MD, David J. Gnarra, MD, Victor S Blanchette, FRCP, Kun Nie, Melissa Eisen, MD, Dietmar Berger, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 680.
https://doi.org/10.1182/blood.V114.22.680.680
Published: 2009
Journal Articles

Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS).

Janet K. Dale, RN, Susan Price, RN, Jean Tretler, RN, Patricia Aldridge, RN, Stephanie Montague, RN MSN, Joie Davis, APRN, Fred Gill, MD, Kip R. Hartman, MD, Linda C. Stork, MD, David J. Gnarra, MD, Lakshmanan Krishnamurti, MD, Jennifer Puck, MD, Thomas Fleisher, MD, V. Koneti Rao, MD
Journal: Blood
Blood (2007) 110 (11): 1319.
https://doi.org/10.1182/blood.V110.11.1319.1319
Published: 2007